Simon T. Hodgson - Concepedia

Author

Simon T. Hodgson

GlaxoSmithKline (United Kingdom)

Also Known As

Hodgson, Simon T., S Hodgson, S. T. HODGSON, S.T. Hodgson, Simon Hodgson, Simon T Hodgson, Simon T. Hodgson

Publications

963

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Wellcome Trust Age UK University of Nottingham Evotec (United Kingdom)

About

Simon T. Hodgson is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	432
2	Natural Sciences	10	10	356
3	Engineering	8	8	218
4	Allergy	2	2	82
5	Health Sciences	1	1	10

Simon T. Hodgson

Publications

894

Citations

H-Index

Page 1

	Year	Citations
Effect of reactive pharmacy intervention on quality of hospital prescribing. Christopher J. Hawkey, Simon T. Hodgson, Aaron D. Norman, BMJ	1990	118
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine Robert J. Young, Richard M. Beams, Keith D. Carter, Bioorganic & Medicinal Chemistry Letters Acetamidine DerivativesBioorganic ChemistryBiochemistryReactive Nitrogen SpecieNatural Sciences	2000	71
Discovery of Further Pyrrolidine <i>trans</i>-Lactams as Inhibitors of Human Neutrophil Elastase (HNE) with Potential as Development Candidates and the Crystal Structure of HNE Complexed with an Inhibitor (GW475151) Simon J. F. Macdonald, Michael D. Dowle, Lee A. Harrison, Journal of Medicinal Chemistry Crystal StructurePharmaceutical ScienceHne ComplexedPharmacotherapyChemical Biology	2002	54
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study Anthony Cahn, Simon T. Hodgson, Robert C. Wilson, BMC Pharmacology and Toxicology AsthmaInflammatory Lung DiseaseLung InflammationAllergy MedicineImmunology	2013	52
Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists Laura Ajram, Malcolm Begg, Robert J. Slack, European Journal of Pharmacology	2014	50
The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase—GW311616A a development candidate Simon J. F. Macdonald, Michael D. Dowle, Lee A. Harrison, Bioorganic & Medicinal Chemistry Letters InflammationGranulocyteDevelopment CandidateMedicineImmunology	2001	46
Synthesis and Structure–Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists Panayiotis A. Procopiou, John W. Barrett, Nicholas P. Barton, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyChemistryStructure–activity RelationshipsPharmaceutical Chemistry	2013	43
The protecting–directing role of the trityl group in syntheses of pyrrole derivatives: efficient preparations of 1-H-pyrrole-3-carboxylic acid and 3-acyl-, 3-amino-, and 3-bromo-1-tritylpyrroles Derek J. Chadwick, Simon T. Hodgson Journal of the Chemical Society Perkin Transactions 1 Carbon DioxideDerivativesEngineeringBiochemistryPyrrole Derivatives	1983	43
Synthesis of β-lactams from π-allyltricarbonyliron (lactone) complexes Gary D. Annis, E. M. HEBBLETHWAITE, Simon T. Hodgson, Journal of the Chemical Society Perkin Transactions 1 β-Lactam CompoundsLactam ComplexesChemical EngineeringEngineeringOrganic Chemistry	1983	43
Synthesis of the β-lactam antibiotic (+)- thienamycin via an intermediate π-allyltricarbonyliron lactone complex Simon T. Hodgson, David M. Hollinshead, Steven V. Ley Tetrahedron EngineeringBioorganic ChemistryOrganic ChemistryPharmacologySynthetic Chemistry	1985	38

Page 1